This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.


  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Apr. 19, 2012

   Home   Mission/Vision    Membership    Corporate Membership    CME/CEU    JMCM    Contact Us

Click Here to view the Journal of Managed Care Medicine

Online CME/CEU Programs
Multiple Myeloma: An Update on Diagnostic and Treatment Strategies

Advanced Treatment of Osteoporosis in Postmenopausal Women

Decreasing the Cost Burden of Fibromyalgia with Early Diagnosis and Management


Announcing the NAMCP Medical Directors Lung Cancer Resource Center. Click here to visit the website.

Be sure to check out the study results of Verinata's Non-Invasive Prenatal Technology. Click here to view the press release.

Click here to check out the "Latest in Clinical Nutrition" DVD available for purchase now!

 



 Genomics

Finger length not affected by fetal testosterone
USA Today    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A scientific hypothesis about men, linking ring finger length to exposure to masculine hormones in the womb, lacks genetic evidence, says a new study. A suggestion has been used to link index-to-ring finger size-ratios to aggression, autism and other male-dominated ailments or behaviors in more than 500 studies since. But a pair of recent studies have questioned this link — one finding no link to aggression and one finding no link to the mutation and finger length ratios. More

Clinical & Economic Utility of a Non-invasive Prenatal Test

Join Susan Garfield, DrPH, Vice President, Bridgehead International, and Anthony Odibo, MD, MSCE at NAMCP’s
Spring Managed Care Forum.

Friday, April 27th, 1:10 – 2:10 PM

Gaylord Palms Hotel
Orlando, FL


Blood test for depression? New research points the way
msnbc    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A simple blood test may one day be all that's needed to help parents figure out whether a child is suffering from clinical depression or normal teenage angst, a new study suggests. In a pilot study of 28 adolescents, scientists showed teenage depression could be diagnosed through a panel of 11 genetic markers, according to a report published in the journal Translational Psychiatry. More

Bigger brain, higher IQ linked with specific genetic variants
TIME    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers have identified two genes that affect brain size and may be linked not only to IQ, but also to risk of developing brain disorders like Alzheimer's disease. Scientists have known that the size and volume of certain parts of the brain are linked to disorders including developmental conditions such as autism and degenerative diseases like Alzheimer's. More

 Biotech/Diagnostics/Personalized Medicine


Study identifies potential treatment for lethal childhood leukemia
Medical Xpress    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Columbia University Medical Center scientists have demonstrated that two related enzymes play a key role in the development of T-cell acute lymphoblastic leukemia, a highly aggressive childhood leukemia that is difficult to treat. The study also showed that a dual PI3K gamma/delta inhibitor can significantly prolong survival in a mouse model of the disease. More

Pricier therapy no better for early prostate cancer
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
A new study suggests expensive, high-tech proton beam radiation doesn't do any more for men with prostate cancer than the most commonly-used option. Proton beam radiation, heavily promoted by facilities that perform the treatment, also came with a higher risk of certain side effects compared to intensity-modulated radiation therapy, researchers found. More


Introducing mySentry™ from Medtronic...

The world’s first remote glucose monitor designed to provide protection from overnight hypoglycemia. MORE
Our activities touch many lives
AstraZeneca is a global, innovation-driven, integrated biopharmaceutical company. We discover, develop, manufacture and market prescription medicines for cancer, cardiovascular, gastrointestinal and infection. MORE


 Regenerative Medicine


Stem cell-AIDS study show engineered cells can kill HIV in mice
The Huffington Post    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Can stem cells cure AIDS? Not yet. But a provocative new study shows human stem cells can be genetically engineered to attack living cells infected with HIV, the virus that causes AIDS. For the study, researchers implanted genetically engineered human blood stem cells into "humanized" mice, rodents in which HIV infection and the resulting disease resemble what happens in HIV-infected humans. More



Ohio State's center to explore repair of organs, limbs
Columbus Business First    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Ohio State University announced it has created a Center for Regenerative Medicine and Cell-Based Therapies, which will apply for newly created grants from the National Institutes of Health. The center's website says it will investigate "revolutionary" treatments using a patient's stem cells to grow new organs and tissues, techniques currently limited for use in tissues such as skin and bone. It could help prevent limb loss from chronic wounds in diabetes patients, for example. More

 Emerging Medical Technologies


3-D, 'DIY drugstores' in development
BBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Researchers at Scotland's Glasgow University have developed a process which they say can "print" drugs. They are using 3-D printing technology which could lead to people having a "personal pharmacy" dispensing medicines at home. A variety of molecules have already been made, including some anti-cancer drugs. The team said its research could make it possible to diagnose an illness before it occurs — and produce a cure. More

3 apps make your smartphone a pocket doctor
App Attack via Fox News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
It's allergy season again. Looking for a solution? Your smartphone can guide you to professional care and empower you to make better health choices. Here are a few pocket-worthy apps to download. More

 Managed Healthcare News


US cites Assurant unit over health premium hike
Reuters    Share    Share on FacebookTwitterShare on LinkedinE-mail article
U.S. officials have cited two health insurers for excessive premium increases, under consumer protection rules of the healthcare reform law that could soon be nullified by the Supreme Court. The Department of Health and Human Services called on Assurant's Time Insurance and United Security Life and Health Insurance to either offer rebates to customers in six states or rescind premium hikes ranging up to 24 percent. More

Dual-eligible demos raise patient-access concerns
American Medical News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Members of an advisory board that recommends Medicare policy to Congress worry patients could face access-to-care problems as a result of demonstration projects planned for poor, disabled beneficiaries who qualify for both Medicare and Medicaid. More

 FDA: New Treatments and Technology


FDA tangles with wireless medical-app makers
Politico    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An onslaught of mobile health technology has forced an arranged marriage between smartphone app makers and the Food and Drug Administration — because someone had to regulate them. There's just one problem: Many of the tech wizards aren't used to FDA supervision. And now, both sides are struggling to figure out how to live with each other. More

California to test HIV-prevention pill
Los Angeles Times    Share    Share on FacebookTwitterShare on LinkedinE-mail article
California will test an HIV-prevention pill in an attempt to slow the spread of the disease in the state, researchers say. The pill, already used to treat HIV patients, will be prescribed to 700 gay and bisexual men and transgender women in Los Angeles, San Diego and Long Beach who are high-risk but not infected. The pill, under the name Truvada, is already approved by the Food and Drug Administration for treating HIV but not for prophylactic use. More

FAST FACTS
"Depression is caused by a combination of genetic, environmental, biological and psychological factors. Certain types tend to run in families, and certain genes may predispose some people, according to the National Institute of Mental Health."
 
Genomics Biotech and Emerging Medical Technologies Institute eBrief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Christine Kraly, Content Editor, 469.420.2685   
Contribute news

This edition of the Genomics Biotech and Emerging Medical Technologies Institute eBrief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
Recent issues
April 12, 2012
April 5, 2012
March 29, 2012
March 22, 2012



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063